- Home
- CBAT vs INCR Comparison
CBAT vs INCR Comparison
Compare CBAT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- INCR
- Stock Information
- Founded
- CBAT 1999
- INCR 1994
- Country
- CBAT China
- INCR Israel
- Employees
- CBAT N/A
- INCR N/A
- Industry
- CBAT Industrial Machinery/Components
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- INCR Health Care
- Exchange
- CBAT Nasdaq
- INCR Nasdaq
- Market Cap
- CBAT 90.4M
- INCR 82.3M
- IPO Year
- CBAT N/A
- INCR N/A
- Fundamental
- Price
- CBAT $0.92
- INCR $1.44
- Analyst Decision
- CBAT
- INCR
- Analyst Count
- CBAT 0
- INCR 0
- Target Price
- CBAT N/A
- INCR N/A
- AVG Volume (30 Days)
- CBAT 635.2K
- INCR 36.7K
- Earning Date
- CBAT 11-18-2025
- INCR 10-08-2025
- Dividend Yield
- CBAT N/A
- INCR N/A
- EPS Growth
- CBAT N/A
- INCR N/A
- EPS
- CBAT N/A
- INCR N/A
- Revenue
- CBAT $145,462,366.00
- INCR $72,158,312.00
- Revenue This Year
- CBAT N/A
- INCR $69.54
- Revenue Next Year
- CBAT $60.02
- INCR $41.75
- P/E Ratio
- CBAT N/A
- INCR N/A
- Revenue Growth
- CBAT N/A
- INCR N/A
- 52 Week Low
- CBAT $0.57
- INCR $1.17
- 52 Week High
- CBAT $1.28
- INCR $1.80
- Technical
- Relative Strength Index (RSI)
- CBAT 44.49
- INCR 38.37
- Support Level
- CBAT $0.93
- INCR $1.42
- Resistance Level
- CBAT $1.00
- INCR $1.52
- Average True Range (ATR)
- CBAT 0.10
- INCR 0.07
- MACD
- CBAT -0.01
- INCR -0.02
- Stochastic Oscillator
- CBAT 7.14
- INCR 14.29
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.